secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viant Technology Inc. (DSP)
CIK:        0001828791
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001828791-24-000030
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Viant audit committee falls below Nasdaq minimum after director resignation; cure period granted
--------------------------------------------------------------------------------

- Director Elizabeth Williams resigned from board and audit committee effective June 5, 2024, not due to any disagreement.
- Nasdaq notified Viant on June 7, 2024, that audit committee has only two independent directors, violating Rule 5605(c)(2).
- Company has cure period until earlier of 2025 annual meeting or June 5, 2025; intends to appoint additional independent director.
- Annual meeting results: stockholders elected Tim Vanderhook and Vivian Yang as Class III directors and ratified Deloitte & Touche as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828791/000182879124000030/0001828791-24-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828791/000182879124000030/dsp-20240604.htm
  HTML page:      https://secwatch.observer/filing/0001828791-24-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer